BPC-157 / TB-500 blends

Also known as BPC 5mg + TB 5mg, Wolverine stack.

Research / investigational listing only. This compound is not available for consumer purchase from Cellular Sequence and must not be confused with shop products.

Research / investigational compoundThis compound does not have an established approved therapeutic dosing schedule. Doses below describe those reported in published scientific research and should not be interpreted as a treatment recommendation.

At-a-glance profile

Classification: Unapproved peptide mixture (research only)
Approval status: Research only · Not approved for human use
Research status: Investigational / reference listing.
Molecular formula: Insufficient reliable evidence identified.
Molecular weight: Insufficient reliable evidence identified.
Sequence: Combination vials of BPC-157 and thymosin-β4 fragments as sold on grey-market lists.
Primary biological target: Insufficient reliable evidence identified.
Half-life: Insufficient reliable evidence identified.
Routes investigated: Insufficient reliable evidence identified.
Human evidence level: D — Primarily animal / preclinical evidence

What is it?

A marketing blend of two unapproved research peptides. A COA does not make a combination lawful to supply as a medicine. Not sold.

Mechanism of action

See individual BPC-157 and TB-500 entries — mixing does not create an approved product.

Not characterised as a registered combination medicine.

What is it being studied for?

None as an approved combination

Investigational findings are not proven clinical benefits unless an authority has labelled that indication.

Evidence level

Overall human evidence grade: D · Primarily animal / preclinical evidence

Human research

Inadequate.

Preclinical research

Animal, cell and in-vitro findings are listed separately from human effects.

See parent peptides.

Doses reported in published research

This section does not provide personalised medical dosing. Values are those reported in papers or protocols. Animal mg/kg doses are not converted to human doses.

Doses reported in human studies

Insufficient reliable evidence identified.

Preclinical / animal study dosing

Insufficient reliable evidence identified.

Pharmacokinetics

Reliable human pharmacokinetic data were not identified for this encyclopaedia entry, or are limited to product information for approved presentations.

Safety

Unknown interactions plus vial-quality risk.

Unknowns. Absence of a published harm signal is not evidence of safety.

Contraindications. Not for human use.

Regulatory status

Not approved.

Educational only. Not in the shop.

Citations

[1] Encyclopaedia note
Encyclopaedia note

For educational and research reference only. This page summarises published scientific literature and does not constitute medical advice, prescribing information or a recommendation to use an investigational compound. Research doses shown describe doses reported in published studies and are not personalised dosing instructions.

Last reviewed 2026-09-13. Research areas: Recovery · Compare peptides